21.
Elevated Serum Advanced Glycation Endproducts in Obese Indicate Risk for the Metabolic Syndrome: A Link Between Healthy and Unhealthy Obesity?
by Uribarri, Jaime
The journal of clinical endocrinology and metabolism, 2015-05, Vol.100 (5), p.1957-1966
22.
Referral for Specialist Follow-Up and its Association with Post-Discharge Mortality among Patients with Systolic Heart Failure (From the National Heart Failure Audit for England &...
by Emdin, Connor A., HBSc
The American journal of cardiology, 2016, Vol.119 (3), p.440-444
23.
Obesity Severity and Duration Are Associated With Incident Metabolic Syndrome: Evidence Against Metabolically Healthy Obesity From the Multi-Ethnic Study of Atherosclerosis
by Mongraw-Chaffin, Morgana
The journal of clinical endocrinology and metabolism, 2016-11, Vol.101 (11), p.4117-4124
24.
Glucosamine and chondroitin for knee osteoarthritis: a double-blind randomised placebo-controlled clinical trial evaluating single and combination regimens
by Fransen, Marlene
Annals of the rheumatic diseases, 2015-05, Vol.74 (5), p.851-858
25.
Projected impact of polypill use among US adults: Medication use, cardiovascular risk reduction, and side effects
by Muntner, Paul, PhD
The American heart journal, 2011, Vol.161 (4), p.719-725
26.
Is there evidence for sex differences in the association between diabetes and cancer? Reply to Dankner R, Boker LK, Freedman LS [letter]
by Ohkuma, Toshiaki
Diabetologia, 2018-11-03, Vol.62 (1), p.201-201
27.
Association Between Sex Hormones and Adiposity: Qualitative Differences in Women and Men in the Multi-Ethnic Study of Atherosclerosis
by Mongraw-Chaffin, Morgana L
The journal of clinical endocrinology and metabolism, 2015-04, Vol.100 (4), p.E596-E600
28.
Rationale and design of dal-PLAQUE: A study assessing efficacy and safety of dalcetrapib on progression or regression of atherosclerosis using magnetic resonance imaging and 18F-fl...
by Fayad, Zahi A., PhD
The American heart journal, 2011, Vol.162 (2), p.214-221.e2
29.
Predictors of Low Clopidogrel Adherence Following Percutaneous Coronary Intervention
by Muntner, Paul, PhD
The American journal of cardiology, 2011, Vol.108 (6), p.822-827
30.
Estimation of individual beneficial and adverse effects of intensive glucose control for patients with type 2 diabetes
by van der Leeuw, Joep
Diabetologia, 2016-12, Vol.59 (12), p.2603–2612-2612
31.
Parenthood and the risk of diabetes in men and women: a 7 year prospective study of 0.5 million individuals
by Peters, Sanne A. E
Diabetologia, 2016-05-18, Vol.59 (8), p.1675-1682
32.
Full hazards of smoking and benefits of stopping for women
by Huxley, Rachel R
The Lancet (British edition), 2013, Vol.381 (9861), p.96-98
33.
Predicting the risk of physical disability in old age using modifiable mid-life risk factors
by Wong, Evelyn
Journal of epidemiology and community health (1979), 2015-01, Vol.69 (1), p.70-76
34.
Blood pressure lowering and cardiovascular risk – Authors' reply
by Sundström, Johan
The Lancet (British edition), 2014, Vol.384 (9956), p.1746-1747
35.
Major surgery in south India: a retrospective audit of hospital claim data from a large community health insurance programme
by Shaikh, Maaz, MPH
The Lancet (British edition), 2015, Vol.385, p.S23-S23
36.
Combined Role of Reduced Estimated Glomerular Filtration Rate and Microalbuminuria on the Prevalence of Peripheral Arterial Disease
by Baber, Usman, MD
The American journal of cardiology, 2009, Vol.104 (10), p.1446-1451
37.
The complementary roles of dynamic contrast-enhanced MRI and 18F-fluorodeoxyglucose PET/CT for imaging of carotid atherosclerosis
by Calcagno, Claudia
European journal of nuclear medicine and molecular imaging, 2013-08-14, Vol.40 (12), p.1884-1893
38.
Degree of blood pressure reduction and recurrent stroke: the PROGRESS trial
by Arima, Hisatomi
Journal of neurology, neurosurgery and psychiatry, 2014-11, Vol.85 (11), p.1284-1285
39.
Rapid Blood Pressure Lowering According to Recovery at Different Time Intervals after Acute Intracerebral Hemorrhage: Pooled Analysis of the INTERACT Studies
by Wang, Xia
Cerebrovascular diseases (Basel, Switzerland), 2015-04, Vol.39 (3-4), p.242-248
40.
Metabolic mediators of body-mass index and cardiovascular risk – Authors' reply
by Danaei, Goodarz
The Lancet (British edition), 2014, Vol.383 (9934), p.2043-2044
